Earnings History Data for Petros Pharmaceuticals, Inc. (PTPI) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Petros Pharmaceuticals, Inc.
Petros Pharmaceuticals Inc. is a men's health company. It engages in identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders. Petros Pharmaceuticals Inc., formerly known as Neurotrope Inc., is based in NEW YORK.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 01-04-2022 | PM | PTPI | Petros Pharmaceuticals, Inc. | 32.27 | -0.72 | 0.00 | 0.00 | Petros Pharmaceuticals GAAP EPS of -$0.83, revenue of $7.81M [4/1/2022 7:33 AM] |
1.38 | -0.08 (-5.48%) |
1.41 | -0.05 (-3.42%) |
1.05 - 5.20 | 332,844 | 660,000 | 9,142 | ||
| 15-11-2021 | AH | PTPI | Petros Pharmaceuticals, Inc. | 28.14 | -0.17 | 0.00 | 0.00 | Petros Pharmaceuticals reports Q3 results [11/15/2021 5:25 PM] |
1.71 | -0.47 (-21.56%) |
1.92 | -0.26 (-11.93%) |
1.56 - 5.96 | 885,933 | 30,250,000 | 62,010 | ||
| 17-08-2021 | PM | PTPI | Petros Pharmaceuticals, Inc. | 29.49 | -0.45 | 0.00 | -0.65 | Petros Pharmaceuticals reports Q2 results [8/17/2021 9:32 AM] |
2.51 | -0.20 (-7.38%) |
2.89 | 0.18 (6.64%) |
1.80 - 5.96 | 40,347 | 40,000 | 804 | ||
|
||||||||||||||||||